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Background: Small interfering RNAs (siRNAs) have been used to knockdown specific gene expression in various 
cells. Astrocytes and microglial cells play a key role in fundamental central nervous system functions and in chronic 
neuroinflammation. The aims of this study were to determine the optimal concentration of siRNA demonstrating 
efficient transfection and inhibition of gene expression via RNA interference (RNAi) and lower cytotoxicity, in 
primary cultured astrocytes and microglial cells of rats.
Methods: Astrocytes and microglial cells were isolated from the cerebral cortices of 2-day-old rats. Both the cells 
were transfected using transfection reagent (Lipofectamine
TM 2000), and fluorescein-labeled double-stranded RNA 
(dsRNA) or siRNA targeting green fluorescent protein. Transfection efficiency and cytotoxicity of dsRNA, and the 
degrees of RNAi induced by siRNA in these cells, were evaluated at various concentrations of RNA.
Results: Transfection efficiencies of dsRNA in both astrocytes and microglial cells were significantly higher (P < 0.05) 
at the concentrations of 20, 40, and 80 nM than at the concentrations of 0, 5, and 10 nM. There were no significant 
cytotoxicities within the applied concentrations of dsRNA (0-80 nM). The degrees of RNAi induced by siRNA were 
significantly higher (P < 0.05) at the concentrations of 5, 10, 20, 40, 80 nM, and 20, 40, 80 nM in astrocytes and 
microglial cells, respectively, compared with the control (0 nM).
Conclusions: The siRNA concentration of 20 nM may be appropriate to induce RNAi in both astrocytes and 
microglial cells, while demonstrating low cytotoxicity, high transfection efficiency, and effective RNAi. (Korean J 
Anesthesiol 2010; 59: 403-410)
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Introduction
    RNA interference (RNAi) is a naturally occurring mechanism 
for regulating gene expression which has been observed 
in several models of organisms, and is mediated by double 
stranded RNA (dsRNA) [1-3]. The intracellular presence of 
dsRNA homologous to a gene results in post-transcriptional 
gene silencing via induced sequence-specific degradation 
of the corresponding mRNA. In recent pain research, it has 
been demonstrated that astrocytes and microglial cells release 
a variety of proinflammatory cytokines such as interleukin 
(IL)-1β, IL-6, and tumor necrosis factor-α, which contribute 
to the pathogenesis of neuropathic pain [4-7]. Silencing of 
gene expression in glial cells may be an alternative treatment 
approach for neuropathic pain. In practice, small interfering 
RNAs (siRNAs) have been applied successfully to down regulate 
gene expression of neuronal cells in the central nervous system 
[8].
    However, RNAi may result in an artificial dysregulation of 
non-target genes, which are called off-target effects [9]. Off-
target effects can be mainly explained by two mechanisms. 
One is induction of the interferon response in mammalian 
cells after transfection of RNA molecules, and the other is 
unintended targeting of genes that have only low level of 
sequence homology to the RNA molecule [9,10]. In general, 
unwanted effects, such as activation of the interferon response, 
are more likely to occur at high siRNA concentrations [9,11,12]. 
siRNA concentrations of less than 20 nM usually do not lead to 
induction of the interferon response [11], although an earlier 
study observed off-target effects at the concentration of siRNA 
of 10 nM [12]. For the effective and safe application of siRNA 
in astrocytes and microglial cells, it is necessary to establish 
appropriate siRNA concentrations for efficient transfection into 
these cells and silencing of target gene without producing off-
target effects and cytotoxicity.
    The aims of this study were to determine the optimal 
concentrations of siRNA demonstrating efficient transfection 
and inhibition of gene expression via RNAi and lower 
cytotoxicity, in primary cultured astrocytes and microglial cells 
of rats.
Materials and Methods
Materials
    Insulin, transferrin, putrescine, thyroxine, triiodothyronine, 
progesterone, selenium, soybean trypsin inhibitor, bovine 
pancreatic DNase, and bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA). 
Collangenase was purchased from Worthington Biochemical 
Corp. (Lakewood, NJ, USA). Glutamine, 20% BSA soultion, 
Dulbecco’s modified Eagle’s medium (DMEM), trypsin-EDTA, 
L-15 medium, fluorescein-labeled dsRNA oligmer (BLOCK-iT
TM 
fluorescent oligo), transfection reagent (Lipofectamine
TM 2000), 
and fetal bovine serum (FBS) were purchased from Invitrogen 
Corp. (Carlsbad, CA, USA).
Preparation of siRNAs
    The siRNA sequence targeting plasmid encoding green 
fluorescent protein (pEGFP-C1) was selected from a previous 
study and modified [13]. The sequences of anti-green 
fluorescent protein (GFP) siRNAs used were 5'-GCA CGA CUU 
CUU CAA GUC CGC CAdT dG-3' (active anti-GFP siRNA). The 
active anti-GFP siRNA was synthesized from Samchully Pharm. 
Co., Ltd. (Siheung, Korea).
Primary culture of astrocytes and microglial cells
    Two-day-old neonatal Sprague Dawley rats were obtained 
from Orient Bio Co., Ltd. (Seongnam, Korea). The number of 
neonates which were used in one primary culture was 12-
15 heads from one pregnant rat, and five primary cultures 
were conducted in this study. All procedures were approved 
(No. 2006-01-059) by the Institutional Animal Care and Use 
Committee of the Asan Institute for Life Sciences, Asan Medical 
Center, Seoul, Korea. The Committee abides by the dictates 
of the Institute of Laboratory Animal Resources guide [14]. 
Cultures were prepared from the whole brains of 2-day-old 
Sprague Dawley rats using the procedures described in previous 
studies [15,16]. Cortex obtained from neonatal rats, was placed 
in Hanks' balanced salt solution, and then meningeal tissues, 
hippocampus, caudate nucleus, and other internal structures 
were removed to leave only the cortical sheets. The cortical 
tissues were minced gently with pipette and mixed with 
collagenase, and then were incubated for 30 minutes at 37
oC. 
After centrifuging at 1,000 rpm for 5 minutes, the supernatants 
were removed and the tissues were resuspended in trypsin-
EDTA solution. After incubation for 5 minutes at 37
oC, soybean 
trypsin inhibitor and DNase solution were added for 5 minutes. 
After centrifuging at 1,000 rpm for 5 minutes, the supernatants 
were removed, and modified-DMEM was added and tissues 
were triturated into a cell suspension using 5-ml pipette and 
18-gauge needle. Cells were filtered through a mesh bag (40 
μm), mixed with DMEM containing FBS 10%, penicillin 100 
U/ml, and streptomycin 100 mg/ml, and then were plated on 
75 cm
2 culture flasks and kept in DMEM supplemented with 
FBS 10% and the antibiotics in a humidified 5% carbon dioxide 
atmosphere at 37
oC, and the medium was changed every 2 
days. After 12-13 days, mixed glial cultures were separated into 405 www.ekja.org
Korean J Anesthesiol Ki, et al.
astrocytes and microglial cells.
    Mixed glial cultures grown for 12 or 13 days in 75 cm
2 flasks 
were shaken on a rotary platform at 150 rpm for 2 hours at 
37
oC. After shaking, the supernatants were used for harvesting 
the microglial cells, and the remaining source cultures 
were dissociated using trypsin-EDTA, and then collected 
by centrifugation (1,000 rpm for 5 minutes). The cells were 
seeded onto culture plates of each experiment and were 
cultured for 24 hours before being used as astrocyte cultures. 
Harvested supernatants were seeded onto culture plates of each 
experiment, and then were incubated for 10 minutes at 37
oC. 
Non-adherent or weakly adherent cells were removed by gentle 
shaking and washed out. The remaining cells were cultured for 
24 hours and used as microglial cultures.
Immunocytochemistry
    The astrocytes and microglial cells were seeded onto poly-D-
lysine coated coverslips (BD BioCoat, BD Biosciences, San Jose, 
CA, USA) at 2 × 10
4 cells/cm
2 and 4 × 10
4 cells/cm
2, respectively, 
and cultured for 24 hours before staining. The cultures were 
fixed with paraformaldehyde 4% in phosphate-buffered saline 
(PBS) 0.1 M for 10 minutes and rinsed three times with PBS 0.1 
M. Cells were incubated with 0.25% Triton X-100 for 10 minutes 
at room temperature. Non-specific binding was blocked with 
10% BSA for 30 minutes at room temperature. Subsequently, 
cultures were incubated with mouse monoclonal antibodies (1 : 
200 dilution) to the specific markers of microglia (OX-42 against 
CD 11b surface antigen, ABR, Golden, CO, USA) or astrocytes 
(glial fibrillary acidic protein [GFAP], Sigma-Aldrich, Inc., St. 
Louis, MO, USA) in the blocking buffer for 24 hours at 4
oC. After 
washing three times with PBS, the cells were incubated with the 
secondary antibody (Alexa Fluor 488 goat anti-mouse IgG for 
GFAP, Alexa Fluor 594 goat anti-mouse IgG for OX-42, 1 : 1,000 
dilution, Molecular Probes, Eugene, OR, USA) for 2 hours at 
room temperature and rinsed. The preparations were mounted 
in fluorescent mounting medium (Dako, Glostrup, Denmark) 
and examined using a confocal fluorescence microscope 
(Leica TCS SP2, Leica microsystems, Bensheim, Germany). We 
calculated the percentage of positively immunostained cells (in 
200 cells) in each of the three separate culture preparations.
siRNA uptake assessment
    The primary astrocytes were seeded at a density of 4 × 10
4 
cells/well and microglial cells were seeded at a density of 1 
× 10
5 cells/well in 24-well plate, and then grown for 24 hours 
prior to transfection. Transfection efficiencies of dsRNA in 
astrocytes and microglial cells were tested using fluorescein-
labeled dsRNA oligmer (the BLOCK-iT
TM Fluorescent Oligo), 
which has the same length, charge and configuration as the 
standard siRNA, and is strictly designed for use as a tool for 
siRNA uptake assessment. Fluorescein-labeled dsRNA oligmer 
were prepared in the concentrations of 0, 5, 10, 20, 40 and 80 
nM, and mixed with 1 μl of transfection reagent. The complex of 
dsRNA and transfection reagent was transfected into both the 
cells using Opti-MEM I (Invitrogen Corp.) without serum. This 
medium was replaced with growth medium at 4-6 hours after 
transfection.
Evaluation of siRNA effects using fluorescence detection 
of GFP
    The primary astrocytes were seeded at a density of 1 × 10
5 
cells/well and microglial cells were seeded at a density of 4 
× 10
5 cells/well in 6-well plate, and then grown for 24 hours 
prior to transfection. Anti-GFP siRNA was prepared in the 
concentrations of 0, 5, 10, 20, 40 and 80 nM, and mixed with 
transfection reagent (2.5 μl) and pEGFP-C1 (800 ng). The 
complex was transfected into both the cells using Opti-MEM 
I without serum. This medium was replaced with growth 
medium at 4-6 hours after transfection.
Evaluation of siRNA effects using reverse transcription 
polymerase chain reaction
    The levels of GFP gene products were determined by 
reverse transcription polymerase chain reaction (RT-PCR) as 
described previously [13]. The RNA (500 ng) prepared from 
the transfected cells was reverse-transcribed into first-strand 
cDNA with oligo (dT)15 primer (PrimeScript 1st Strand cDNA 
Synthesis Kit, Takara Korea Biomedical Inc., Seoul, Korea) 
in 20 μl reactions. The PCR was performed with 1 μl of the 
first-strand cDNA solution and 0.5 μM each of the sense and 
antisense primers using PCR kit (PrimeScript 1st Strand cDNA 
Synthesis Kit, Takara Korea Biomedical Inc., Seoul, Korea) for 
30 cycles of denaturation (94
oC, 30 seconds), annealing (62
oC, 
30 seconds) and extension (72
oC, 30 seconds); GFP, or for 30 
cycles of denaturation (94
oC, 30 seconds), annealing (59
oC, 
30 seconds) and extension (72
oC, 30 seconds); cyclophilin. 
Primers and PCR product sizes for the corresponding target 
genes were as follows: GFP (5'-3': forward, AAC GGC CAC AAG 
TTC AGC GTG T; reverse, ACA GCT CGT CCA TGC CGA GAG 
T ; base pair, 642), cyclophilin (5'-3': forward, ATG TGC CAG 
GGT GGT GAC TTC A; reverse, TTG TCC ACA GTC GGA GAT 
GGT; base pair, 379). The PCR products were electrophorated 
on 1.5% agarose gels, stained with ethidium bromide and 
visualized by ultraviolet (UV) illumination. Digital images of the 
PCR products were produced under an UV light. The intensity 
of PCR product staining, which has been shown to be directly 406 www.ekja.org
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proportional to the amount of DNA, was determined using a 
densitometer (VersaDoc Multi-Imaging Analyzer Systems, Bio-
Rad, Hercules, CA, USA). The amount of each PCR product of 
GFP was normalized to cyclophilin levels, a transcript whose 
levels do not change in contused spinal cord [17].
Image analysis
    To evaluate transfection efficiency and modulation effect for 
GFP gene expression by siRNA, fluorescent uptake was assessed 
at 16 hours post-transfection using confocal fluorescence 
microscope (standard FITC filter set; λex = 494 nm, λem = 519 nm 
green). Images from the confocal microscope were stored on 
hard disk (512 × 512 pixel format) or erasable optical disk. The 
nuclear and total cellular fluorescence in each confocal slice 
were determined using image software (ImageJ; NIH image, 
http://rsbweb.nih.gov/nih-image). For each complex, we 
randomly selected two areas per well, and then the transfection 
efficiency of each trasfection reagent and fluorescein-labeled 
dsRNA oligmer complex, and modulation effect for GFP gene 
expression by siRNA were expressed as a percentage of the 
transfected areas (astrocyte, measured fluorescent positive 
area/total measured area) and transfected cells (microglia, 
counted fluorescent positive cell/total counted cell).
Cytotoxicity of dsRNA
    3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT, Sigma-Aldrich, Inc., St. Louis) reduction activity 
was measured with a colorimetric assay. The primary astrocytes 
were seeded at a density of 5 × 10
4 cells/well and microglial cells 
were seeded at a density of 5 × 10
5 cells/well in 96-well plate, 
and then grown for 24 hours prior to transfection. At 4 hours 
after transfection with transfection reagent (0.25 μl) and dsRNA, 
which was prepared in the concentrations of 0, 5, 10, 20, 40 and 
80 nM, the mixture was replaced with 0.1 ml of fresh medium. 
The cells were incubated for an additional 24 hours at 37
oC. 
Ten L of MTT dye solution (5 mg/ml in phosphate buffer pH 
7.4) was added to each well. After 2 hours of incubation at 37
oC 
and 5% CO2 for exponentially growing cells and 15 minutes 
for steady-state confluent cells, the medium was removed and 
formazan crystals were solubilized with 100 μl of 0.04 N-HCl 
in isopropyl alcohol, and the solution was vigorously mixed to 
dissolve the reacted dye. The absorbance of each well was read 
on a microplate reader (Spectramax 340PC, MDC, Sunnyvale, 
CA, USA) at 570 nm. The spectrophotometer was calibrated to 
zero absorbance, using culture medium without cells. The cells 
that were exposed to 10 μM ionomycin (Sigma-Aldrich, Inc.) for 
24 hours were used 100% cell death (full-kill) [18]. Cell viability 
was calculated as follows:
where ei	refers to the absorbance of each well containing 
each dsRNA concentrations. Mean sham result is the mean 
absorbance of five replicated 0 nM concentration. Mean FK 
result is obtained by averaging the results from each of the 
wells treated with a substance that produces 100% cell death 
conditions. Tests were performed as five replicated experiments 
of the three experiments (n = 15).
Statistical analysis
    The experimental results were expressed as mean ± SD. The 
cytoxicity, transfection efficiency and GFP gene expression 
levels between the concentrations of dsRNA or siRNA were 
compared using Kruskal-Wallis test, and then pairwise multiple 
comparisons were performed using the Mann-Whitney U-test. 
The Mann-Whitney U-test was used to compare the mRNA 
expression levels between the different concentrations of anti-
GFP siRNAs. A value of P < 0.05 was considered statistically 
significant. The statistical analyses were performed with SPSS 
(version 12.0, SPSS Inc., Chicago, IL, USA).
Results
Purity of primary cultured cells
    Astrocytes and microglial cells from mixed glial cultures 
were isolated to identify the cell types in which siRNA acts. The 
purities of the astrocytes and microglial cultures were 96% and 
94%, respectively, as determined by immunocytochemistry 
(Fig. 1).
Transfection efficiency of dsRNA in primary cultured 
astrocytes and microglial cells 
    With increase in fluorescent-labeled dsRNA concentration, 
transfection efficiencies of dsRNA on primary cultured astro-
cytes and microglial cells increased. Transfection efficiencies of 
dsRNA in both astrocytes and microglial cells were significantly 
higher (P < 0.05) at the concentrations of 20, 40, and 80 nM than 
at the concentrations of 0, 5, and 10 nM (Fig. 2).
Cytotoxicity of dsRNA in astrocytes and microglial 
cells
    As shown in Fig. 3, there was no significant cytotoxicity within 
the applied concentrations of fluorescein-labeled dsRNA in 
both astrocytes and microglial cells.
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Modulation of GFP gene expression by siRNA
    As shown in image analyses of fluorescence (Fig. 4 and 5), 
silencing effects induced by anti-GFP siRNA on the expression 
of GFP gene were significantly higher (P < 0.05) at the 
concentrations of 5, 10, 20, 40, 80 nM, and 20, 40, 80 nM in 
astrocytes and microglial cells, respectively, compared with the 
control (0 nM). The expression levels of GFP mRNA evaluated 
Fig. 1. Representative photomi-
crographs of secondary cultures of both 
astrocytes (A) and microglial cells (B) 
subjected to immunocytochemical 
analysis. Left panels show phase-
contrast micrographs and right panels 
show fluorescence micrographs. The 
majority of cells in astrocyte cultures 
were positively stained with an antibody 
to glial fibrillary acidic protein. The 
majority of cells in microglial cultures 
were immunostained with OX-42 (×200, 
scale bar = 100 μm. OX-42 = specific 
markers of microglia [antibody against 
CD 11b surface antigen]).
Fig. 2. Transfection efficiency of dsRNA in both primary cultured astrocytes (A) and microglial (B) cells. The transfection efficiency was 
observed by confocal fluorescence microscope (standard fluorescein isothiocyanate filter set; λex = 494 nm, λem = 519 nm green) and the 
number of transfected cells was analyzed by ImageJ program (NIH image, http://rsbweb.nih.gov/nih-image). The transfected cells values are 
means ± SD of three independent experiments (*P < 0.05, n = 6). dsRNA: fluorescein-labeled dsRNA oligmer.408 www.ekja.org
RNA interference in the rat glial cells  Vol. 59, No. 6, December 2010
using RT-PCR in both astrocytes and microglial cells were 
consistent with image analyses for fluorescence (Fig. 6).
Discussion
    High transfection efficiency of siRNA-lipopolymer complexes 
is of crucial importance for gene silencing in transfected cells. 
Transfection efficiency of fluorescein-labeled dsRNA was 
determined in HeLa and P19 cells, which was observed to 
be high in the earlier studies [19,20]. In this study, astrocytes 
and microglial cells also showed high transfection efficiencies 
(>80%) of fluorescein-labeled dsRNA at the concentrations of 
20 nM or higher, which were concentration-dependent within 
these ranges of dsRNA concentrations (20-80 nM) as well.
    There have been controversies regarding the concentration 
of transfected dsRNA molecules to prevent off-target effects. In 
earlier studies, these concentrations were known to be 5, 10, 
or 20 nM [11,12,21]. This study demonstrated that the lowest 
in vitro concentrations of anti-GFP siRNA silencing a target 
gene were different between astrocytes (5 nM) and microglial 
cells (20 nM). In addition, fluorescein-labeled dsRNA showed 
poor transfection efficiencies at the concentrations of less 
than 20 nM. Therefore, the lowest concentrations of siRNA for 
silencing target mRNAs in both the cells should be about 20 
nM, considering the in vivo conditions where mixed astrocytes 
and microglial cells exist. Off-target effects of siRNA were first 
screened by microarray profiling experiments [11,21-23], and 
then confirmed by evaluating the expression of specific genes 
Fig. 3. The cytotoxicity of dsRNA in both astrocytes (A) and microglial cells (B). Cells were transfected with transfection reagent and dsRNA 
complex, which were prepared in concentrations of 0, 5, 10, 20, 40 and 80 nM of dsRNA, and incubated for 4 hours and an additional 24 hours at 
37
oC. The cellular viability was measured by MTT assay. The percent viability of cells are means ± SD of three independent experiments (n = 15). 
dsRNA: fluorescein-labeled dsRNA oligmer.
Fig. 4. The degree of RNAi increased with increasing concentration of anti-GFP siRNA in astrocytes (upper panels) and microglial cells (lower 
panels). Cells were transfected with plasmid encoding GFP (pEGFP-C1) of 800 ng and each concentration of anti-GFP siRNA (A: 0 nM, B: 5 nM, 
C: 10 nM, D: 20 nM, E: 40 nM, and F: 80 nM). The fluorescence of GFP was observed under confocal fluorescence microscope (×200, scale bar = 
100 μm). RNAi: RNA interference, GFP: green fluorescent protein, siRNA: small interfering RNAs.409 www.ekja.org
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such as CYLD and SOAT gene in siRNA targeting GFP [21]. The 
types of off-target effects associated with siRNAs were currently 
recognized as follows: microRNA-like off-target effects [9,22], 
immune stimulation [12], and saturation of the RNAi machinery 
[24]. Hence, understanding the sources of off-target activity is 
yielding insights into the techniques to mitigate them.
    The MTT assay for cell viability evaluation has been described 
as a suitable method for detection of biomaterial toxicity, and 
this assay relies on the mitochondrial activity of cultured cells 
and represents a parameter for their metabolic activity [25]. The 
mitochondrial metabolism of astrocytes and microglial cells 
was assumed to be stable at the concentrations of RNA applied 
in this study.
    Since siRNA molecules cannot cross the blood-brain barrier, 
direct site injections into the central nervous system, such 
as intrathecal administration, are required under in vivo 
conditions [26]. In the field of pain research, typically, 1-2 g of 
siRNA daily are administered intrathecally into rats weighing 
between 200-220 g, in order to induce gene silencing [26,27]. 
In addition, the volume of injectate into the intrathecal space of 
rats should not exceed 10% of the total cerebrospinal fluid (CSF) 
volume (approximately 250 L) to avoid CSF hypervolemia and 
to minimize costs associated with transfection reagents [26].
    In conclusion, the lowest concentration of dsRNA required 
for efficient transfection into astrocytes and microglial cells 
was 20 nM. The dsRNA concentrations of 80 nM or lower did 
not cause cytotoxic effects in both the cells. In addition, the 
lowest concentrations of siRNA required for inhibiting the 
expression of targeted gene (GFP) in astrocytes and microglial 
cells were 5 nM and 20 nM, respectively. Therefore, the siRNA 
concentration of 20 nM may be appropriate to induce RNAi in 
primary cultured astrocytes and microglial cells of rats, while 
demonstrating low cytotoxicity, high transfection efficiency, 
and effective RNAi.   
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